Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$6.26 - $14.42 $247,608 - $570,368
-39,554 Reduced 72.21%
15,219 $110,000
Q2 2021

Aug 11, 2021

BUY
$20.08 - $29.02 $440,474 - $636,582
21,936 Added 66.8%
54,773 $1.12 Million
Q1 2021

May 14, 2021

BUY
$27.0 - $32.48 $87,075 - $104,747
3,225 Added 10.89%
32,837 $961,000
Q4 2020

Feb 16, 2021

BUY
$26.68 - $38.23 $790,048 - $1.13 Million
29,612 New
29,612 $885,000

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $55.1M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.